JANELLA SCHROEDER: Open Payments
NPI 1851721948 · WATSEKA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 64 payments from 10 companies in 2025. Trend: 2023 $323 · 2024 $855 · 2025 $1,208
Food & beverage: $1,097Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $404 |
| Alkermes, Inc. | 13 | $216 |
| Neurocrine BioSciences, Inc. | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $107 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| ABBVIE INC. | 2 | $33 |
| Lundbeck LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: ARISTADA, AUSTEDO XR, UZEDY, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, Auvelity, COBENFY.
Industry payments across IL — which companies pay providers there.
